Hybrigenics

Hybrigenics this week announced that it has appointed Etienne Formstecher CEO of its Hybrigenics Services subsidiary.

NEW YORK (GenomeWeb News) – French biopharmaceutical firm Hybrigenics said recently that it has acquired the genomics business of biotech company Imaxio for an undisclosed amount.

French biotech firm Hybrigenics said this week that it has incorporated a US-based subsidiary, Hybrigenics Corporation.

NEW YORK (GenomeWeb News) – Hybrigenics has acquired the yeast two-hybrid assets of Swiss biotech firm Dualsystems Biotech.

NEW YORK (GenomeWeb News) – An international group of collaborators from academia and the business sector will partner to use integrative systems biology and comparative genomics approaches to study age-related human brain diseases with a particular focus on discovering new molecular targets and

Hybrigenics has appointed Albert Saporta to its board as a non-executive independent director. He replaces Eric Castaldi, who has resigned.

French biotech firm Hybrigenics said this week that it has renewed a three-year, $2.4 million research services agreement with an unnamed US life sciences company.

This story originally ran on Feb. 1.
French biotech firm Hybrigenics this week reported €6.6 million ($8.7 million) in revenues for 2011, up 45 percent from €4.5 million in 2010.

This story originally ran on Oct. 18
French biotech company Hybrigenics this week reported €1.85 million ($2.52 million) in first-half revenues from its proteomics services business, up eight percent from €1.71 million in the first half of 2010.

Movers & Shakers

Premium

Vermillion announced this week that Sandra Gardiner has resigned as vice president and chief financial officer and is leaving the company to take a job with an undisclosed firm in the San Francisco Bay Area.

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.